Compounds > sch 58261
Page last updated: 2024-09-05

sch 58261 and n-((1s,trans)-2-hydroxycyclopentyl)adenosine

sch 58261 has been researched along with n-((1s,trans)-2-hydroxycyclopentyl)adenosine in 1 studies

Compound Research Comparison

Studies
(sch 58261)		Trials
(sch 58261)		Recent Studies (post-2010)
(sch 58261)		Studies
(n-((1s,trans)-2-hydroxycyclopentyl)adenosine)		Trials
(n-((1s,trans)-2-hydroxycyclopentyl)adenosine)		Recent Studies (post-2010) (n-((1s,trans)-2-hydroxycyclopentyl)adenosine)
460142942

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, ZG; Jacobson, KA1

Reviews

1 review(s) available for sch 58261 and n-((1s,trans)-2-hydroxycyclopentyl)adenosine

ArticleYear
Adenosine receptors as therapeutic targets.
    Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3

    Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship

2006